share_log
Breakings ·  Jun 25 19:32
Wave Life Sciences: Sees Current Cash & Cash Equivalents Sufficient to Fund Operations Into Q4 2025
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment